Accelerating neuroscience research

±¬ÁÏTV has some of the best minds in the world working on research into MND, Parkinson's, stroke, dementia and more neurological conditions. When you make a gift you'll support the vital equipment needed to find treatments for these cruel diseases.

How you can help

Architect's design of the new SITraN expansion
The new expansion to SITraN will increase lab space to speed up treatments for devastating conditions like MND
Make a regular gift to medical research 

The impact of your support

Sean portrait

Your kindness develops more treatments

A subtype of MND caused by a faulty SOD1 gene runs in Sean’s family. He is currently receiving Tofersen at Sheffield Teaching Hospitals under the care of Professor Shaw.
Gemma in her mobility aid with a tracheostomy tube in her neck
Gemma needed a tracheostomy tube to help suction saliva so she could breathe

Your gift brings hope to families coping with MND

A passionate supporter of MND research at Sheffield, Gemma sadly lost her battle with MND in 2023. Helping SITraN find a cure for MND means so much to her parents Nigel and Sharon.

Updates from SITraN

Two women in hard hats and high vis jackets laying a ceremonial brick for the new SITraN building expansion
SITraN's expansion 
Dr Heather Mortiboys leading a team of Parkinson's researchers in a lab
Parkinson's research 
Photo of a surgeon talking to a patient in a hospital bed
Stroke, Dementia and MS research 
Scientist reviewing research

A world-first NHS trial to transform care

Led by the ±¬ÁÏTV in partnership with Sheffield Teaching Hospitals NHS Foundation Trust, people living with MND will benefit from innovative remote monitoring tech, helping them to access breathing support from home.
SITraN building

SITraN's vision

Opened by Queen Elizabeth II in 2010, SITraN is at the forefront of research for neurodegenerative diseases. Professor Dame Pamela Shaw, Director of SITraN, talks about the world-leading facility.

SITraN: a global centre for excellence

  • Successfully led 250 clinical studies to improve our understanding of neurological diseases and create new treatments.
  • Pioneered the development of , a global breakthrough and turning point in MND treatment.